Portal de Periódicos da CAPES

Revision and update on clinical practice guideline for liver cirrhosis

2012; Korean Association for the Study of the Liver; Volume: 18; Issue: 1 Linguagem: Inglês

10.3350/kjhep.2012.18.1.1

2093-8047

Ki Tae Suk, Soon Koo Baik, Jung‐Hwan Yoon, Jae Youn Cheong, Yong Han Paik, Chang Hyeong Lee, Young Seok Kim, Jin Woo Lee, Dong Joon Kim, Sung Won Cho, Seong Gyu Hwang, Joo Hyun Sohn, Moon Young Kim, Young Bae Kim, Jae Geun Kim, Yong Kyun Cho, Moon Seok Choi, Hyung Joon Kim, Hyun Woong Lee, Seung Up Kim, Ja Kyung Kim, Jin‐Young Choi, Dae Won Jun, Won Young Tak, Byung Seok Lee, Byoung Kuk Jang, Woo Jin Chung, Hong Soo Kim, Jae Young Jang, Soung Won Jeong, Sang Gyune Kim, Oh Sang Kwon, Young Kul Jung, Won Hyeok Choe, June Sung Lee, In Hee Kim, Jae‐Jun Shim, Gab Jin Cheon, Si Hyun Bae, Yeon Seok Seo, Dae Hee Choi, Se Jin Jang,

Drug-Induced Hepatotoxicity and Protection

Table 1.Grading evidence and recommendations Evidence Notes High quality Further research is very unlikely to change our confidence in the estimate of effect A Moderate quality Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate B Low quality Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.Any change of estimate is uncertain C Recommendation Notes Strong Factors influencing the strength of the recommendation included the quality of the evidence, presumed patient-important outcomes, and cost 1 Weak Variability in preferences and values, or more uncertainty.Recommendation is made with less certainty, higher cost or resource consumption 2